For safety information, refer to the prescribing details below.
Experience EBGLYSS™ (lebrikizumab-lbkz): Consider This Option for Your Patients
FREE NON-CME Dermatology Webinar
Tuesday, March 18, 2025 | 5:00 PM - 6:00 PM PST
Peter Lio, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Eli Lilly and Company. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Join us for “Experience EBGLYSS™ (lebrikizumab-lbkz)”, an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features data on early and long-term efficacy, safety, dosing information, and how to get patients started on EBGLYSS.
Learning Objectives:
Understand the mechanism of action of lebrikizumab-lbkz in targeting IL-13
Review clinical trial data on the efficacy and safety of EBGLYSS™
Identify appropriate patient candidates for lebrikizumab-lbkz
Discuss strategies for integrating lebrikizumab-lbkz into clinical practice
Join us live! Be part of the experience—don’t miss out!
Sponsored by
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
MAT-US-2407348 – v1.0 – P Exp Date: 01/10/2025
SAFETY SUMMARY
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com
This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.
LK CON BS AD APP
INDICATION
EBGLYSS™ (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
SAFETY SUMMARY INDICATION
SAFETY SUMMARY INDICATION
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- ☐ Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com
This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.
EBGLYSS™ (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
((Webinar Title))
FREE NON-CME Dermatology Webinar
((Day, Date, | Time))
Tuesday, February 25, 2025 | 5:00 PM - 6:00 PM PST
((Speaker Headshot, | Speaker First, Last Name, Degree))
Raja Sivamani, MD MS AP
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend.
((WEBCAST DESCRIPTION))
Learning Objectives:
((OBJECTIVES))
Discuss the various forms of stem cells that are found within the skin
((OBJECTIVES))
Summarize the integrative approach to hair health and the role of growth factor based therapies
((OBJECTIVES))
Evaluate the role of stem cell derived topical therapies for post-procedure care
Tailor post-procedure protocols to individual needs
((OBJECTIVES))
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
FREE NON-CME Dermatology Webinar
Tuesday, February 25, 2025 | 5:00 PM - 6:00 PM PST
Raja Sivamani, MD MS AP
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
In this webinar, we will explore the latest integrative approaches to treating hair health and enhancing recovery following popular aesthetic treatments such as laser therapies, microneedling, and chemical peels. The integrative toolkit approach to hair health will be emphasized with a focus on the role of the delivery of growth factors. Featuring expert insights, the session will cover a range of topics from advanced post-procedure care protocols to the most recent innovations in hair restoration techniques.
Learning Objectives:
Discuss the various forms of stem cells that are found within the skin
Summarize the integrative approach to hair health and the role of growth factor based therapies
Evaluate the role of stem cell derived topical therapies for post-procedure care
Tailor post-procedure protocols to individual needs
Join us live! Be part of the experience—don’t miss out!
Brought to you by
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
MAT-US-2407348 – v1.0 – P Exp Date: 01/10/2025
SAFETY SUMMARY INDICATION
SAFETY SUMMARY INDICATION
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue, or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or visit ebglyss.lilly.com.
EBGLYSS™ (EHB-glihss) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue, or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or visit ebglyss.lilly.com.
EBGLYSS™ (EHB-glihss) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
UPCOMING MASTER CLASSES AND LIVE CME LECTURES
NON-CME
To Be Announce...
February 25, 2025 | 5:00 PM - 6:00 PM PST
Raja Sivamani, MD MS AP
Live Non-CME Lecture
In this webinar, we will explore the latest integrative approaches to approaching hair health and enhancing recovery following popular aesthetic treatments such as laser therapies, microneedling, and chemical peels. The integrative toolkit approach to hair health will be emphasized with a focus on the role of the delivery of growth factors. Featuring expert insights, the session will cover a range of topics from advanced post-procedure care protocols to the most recent innovations in hair restoration techniques.
Learning Objectives:
- Discuss the various forms of stem cells that are found within the skin
- Summarize the integrative approach to hair health and the role of growth factor based therapies
- Evaluate the role of stem cell derived topical therapies for post-procedure care
- Tailor post-procedure protocols to individual needs
Supported by NeoGenesis Inc
THE SPEAKERS
We brought together medical experts that have devoted their time and energy to
advancing the field of integrative dermatology
Jessica Maloh, ND
NON-CME MASTER CLASS
Functional Medicine Testing of the Microbiome PanelRecording now available
Jennifer Ornelas, MD
NON-CME MASTER CLASS
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel
Read Bio
7/12/22 | 5:00 PM PT
Julie Harper, MD
NON-CME MASTER CLASS
Non-CME
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel7/12/22 | 5:00 PM PT
Read Bio
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel7/12/22 | 5:00 PM PT
Kent Shih, MD
NON-CME MASTER CLASS
Co-managing Patients with Locally Advanced Basal Cell Carcinoma (BCC) in an Evolving Treatment Landscape
Read Bio
5/24/22 | 5:00 PM PT
Michael Traub, ND DHANP FABNO
NON-CME MASTER CLASS
Functional Medicine Testing of the Microbiome Panel6/21/22 | 5:00 PM PT
Neal Bhatia, MD
MASTER CLASSES AND LECTURES
Non-CME
Read Bio
Strategies to Reduce...Panel
7/12/22 | 5:00 PM PT
All Benzoyl Peroxides...
8/30/22 | 5:00 PM PT
Peter Lio, MD
Raja Sivamani, MD MS AP
MASTER CLASSES AND LECTURES
Non-CME
Strategies to Reduce...Panel
7/12/22 | 5:00 PM PTThe Use of Botanicals and Supplements for Acne7/19/22 | 5:00 PM PT
Read Bio
Strategies to Reduce...Panel
7/12/22 | 5:00 PM PTThe Use of Botanicals and Supplements for Acne7/19/22 | 5:00 PM PT
Raj Chovatiya, MD PhD MSCI FAAD
Snehal Amin, MD
NON-CME MASTER CLASS
Co-managing Patients with Locally Advanced Basal Cell Carcinoma (BCC) in Evolving Treatment Landscape
Read Bio
5/24/22 | 5:00 PM PST
Tina Bhutan, MD MAS
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psotiasis - Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Ted Lain, MD MBA
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psoriasis - Challenges from the clinic 6/4/24 | 5:00 PM PST
Read Bio
THE SPEAKERS
We brought together medical experts that have devoted their time and energy to
advancing the field of integrative dermatology
Brennan Dedecker, ND
Learn More
non-CME Master Class:
Elevate Your Membership: The Extraordinary World of Premium
3/12/24 | 5:00 PM PST
Read Bio
3/12/24 | 5:00 PM PST
Hadar Lev-Tov, MD MAS
Learn More
Non-CME Master Class:
Office-Based Procedures for HS That Anyone Can Do!
Read Bio
Recording now available
Jason Hawkes, MD MS FAAD
Learn More
James Song, MD
Learn More
Jessica Maloh, ND
Learn More
Non-CME Master Class:
Non-CME
Functional Medicine Testing of the Microbiome PanelRecording now available
Read Bio
Functional Medicine Testing of the Microbiome PanelRecording now available
Jennifer Ornelas, MD
Learn More
Non-CME Master Class:
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel
Read Bio
7/12/22 | 5:00 PM PT
Julie Harper, MD
Learn More
Non-CME Master Class:
Non-CME
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel7/12/22 | 5:00 PM PT
Read Bio
Strategies to Reduce the Use of Topical and Systemic Antibiotics and Antibiotic Resistance in Acne and Rosacea Panel7/12/22 | 5:00 PM PT
Kent Shih, MD
Learn More
Non-CME Master Class:
Co-managing Patients with Locally Advanced Basal Cell Carcinoma (BCC) in an Evolving Treatment Landscape
Read Bio
5/24/22 | 5:00 PM PT
Michael Traub, ND DHANP FABNO
Learn More
NON-CME MASTER CLASS:
Non-CME
Functional Medicine Testing of the Microbiome Panel6/21/22 | 5:00 PM PT
Read Bio
Functional Medicine Testing of the Microbiome Panel6/21/22 | 5:00 PM PT
Neal Bhatia, MD
Learn More
Master Classes and Lectures:
Non-CMEStrategies to Reduce...Panel
7/12/22 | 5:00 PM PTCME Live Lecture
Read Bio
7/12/22 | 5:00 PM PTCME Live Lecture
All Benzoyl Peroxides...
8/30/22 | 5:00 PM PT
Peter Lio, MD
Learn More
Raja Sivamani, MD MS AP
Learn More
Master Classes & Live Lectures:
Non-CME
Strategies to Reduce...Panel
7/12/22 | 5:00 PM PTThe Use of Botanicals and Supplements for Acne7/19/22 | 5:00 PM PT
Read Bio
Strategies to Reduce...Panel
7/12/22 | 5:00 PM PTThe Use of Botanicals and Supplements for Acne7/19/22 | 5:00 PM PT
Raj Chovatiya, MD PhD MSCI FAAD
Learn More
Snehal Amin, MD
Learn More
Non-CME Master Class:
Co-managing Patients with Locally Advanced Basal Cell Carcinoma (BCC) in an Evolving Treatment Landscape
Read Bio
5/24/22 | 5:00 PM PT
Tina Bhutan, MD MAS
Learn More
Non-CME Master Class:
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Ted Lain, MD MBA
Learn More
Non-CME Master Class:
Co-managing Patients with Locally Advanced Basal Cell Carcinoma (BCC) in an Evolving Treatment Landscape
Read Bio
5/24/22 | 5:00 PM PT
WATCH RECORDINGS
Catch Up on the Latest Advancements in Dermatology
Scratching the Surface: Understanding Itch in Prurigo Nodularis
Experts Drs. Sarina Elmariah and Raja Sivamani conducted an educational ADVENT webinar on prurigo nodularis, an itchy dermatological condition. Participants uncovered how clinical signs and itch are influenced by type 2 inflammation, along with essential diagnostic and management considerations for clinical practice.
Supported by Sanofi and Regeneron
Non-CME
An Integrative Approach to Hormones and Stress in Dermatology
This master class to explore the intricate relationship between hormonal imbalances, stress, and skin health. Dermatological conditions often stem from internal factors such as hormonal fluctuations and psychological stressors, in addition to external influences. Understanding the interconnectedness of hormones and stress with dermatological issues can lead to more effective treatment strategies and whole health care for patients. This interdisciplinary approach integrates knowledge from endocrinology, dermatology, psychology, and lifestyle medicine to provide comprehensive care for patients.
Supported by Codex Labs
Non-CME
The Power of Akkermansia and Other Novel Probiotics: Supporting a Holistic Approach to Beauty with Targeted Probiotic Strains
Explore how the gut microbiome, particularly Akkermansia muciniphila, plays a vital role in natural GLP-1 production, healthy weight maintenance, and overall wellness. Join Dr. Joseph Gretzula and Christina O’Connor, RD to learn how this powerful microbe can support clients' aesthetic goals by promoting balanced metabolism and enhanced vitality. Discover actionable strategies to incorporate gut health into your practice and provide comprehensive wellness solutions that align with today’s holistic approach to beauty.
Non-CME
New Insights into Managing Acne Through a Novel Nutraceutical
This master class discusses the evidence supporting the role of the six factors in the development of acne. It also presents clinical results from the use of a novel nutraceutical which addresses these root causes in subjects with non-cystic acne.
Non-CME
Emerging and Novel Over-The-Counter Retinoids: Innovations in Dermatology
This masterclass will focus on a new retinoid ingredient Adapinoid and the emerging clinical evidence in comparison to retinol.
Supported by Actera
Non-CME
Treating the Root Cause of Eczema: The Gut Microbiome Connection
This master class delves into the gut microbiome’s vital role in skin health. Join Dr. Julie Greenberg and Kara Siedman, RD, CDCES, to explore its impact on managing conditions like eczema.
Supported by Pendulum Therapeutics
Non-CME
VITILIGO CASE DISCUSSIONS
Case presentations featuring patients that have vitiligo and highlight our new vitiligo CME series.
Supported by an independent educational grant from Incyte
NON-CME
PSORIASIS CASE DISCUSSIONS: APPROACH TO ALL DISEASE VARIANTS
Case presentations featuring patients that have psoriasis and highlight our new psoriasis and seborrheic dermatitis CME series. Supported by independent educational grants from Arcutis and Dermavant
NON-CME
An Inside-Out Approach to Acne and Rosacea
This lecture will review the role of supplementation and topical therapy in rosacea and acne. The pathophysiological and immunological mechanisms will be reviewed in the context of taking an integrative approach to treatment so that treatment is paired with an understanding of the root cause of disease. The role of the gut and skin microbiome will be reviewed. A practical approach to treatment will be discussed including case based discussions.
Supported by Codex Labs
Non-CME
Chronic Hand Eczema
This lecture focuses on Chronic Hand Eczema (CHE), a persistent dermatological condition with significant implications on patient quality of life and psychological well-being. Leading dermatologist, Dr. Raj Chovatiya, presents current insights into the epidemiology, pathogenesis, diagnosis, and management of CHE.Supported by LEO
Non-CME
Elevate Your Membership: The Extraordinary World of Premium
Premium membership has a lot to offer, and you might be wondering where to start? Join us as we explore key features of the LearnSkin platform and how to optimize the educational content and resources for your professional advancement and patient care. Discover exclusive perks available only to premium members and walk through cases using the new Natural Medicines Database (NMD) integration. Connect with like-minded colleagues and elevate your practice!
Non-CME
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
This webinar will synthesize the previous sessions by reviewing complex cases of psoriasis and psoriatic arthritis and discuss the clinical approach to diagnosis, selection of therapy, and comprehensive long-term management of the disease and overall patient care.
Supported by independent educational grants from Janssen Biotech, Inc and UCB
Non-CME
Sign Up
You don't want to miss out on learning practical pearls to better help your patient's physical and mental health within dermatology.
WHO IS LEARNSKIN
LearnSkin is a dedicated group of dermatologists and integrative medicine practitioners with a mission to support professionals in dermatology. Their goal is to share the latest scientific research and treatment options in dermatology for both Western and Eastern medicine to meet the growing demand for responsible, quality, and evidence-based education bridging conventional and complementary medical approaches.
LearnSkin master classes, programs, and events are designed to provide clinicians like you with skills that expand past what was learned in school, residency, and traditional conferences with the hope you inspire change in your patients and reach better outcomes in their overall care.
Sponsor Prize
RAFFLE PRIZES
Attendees are automatically entered into a drawing to win a prize from LearnSkin or the dermatology webinar sponsor. You must attend live to be eligible and to claim your prize!
SPONSORS
ABBVIE
ACTIVE SKIN REPAIR
AYUSH HERBS
BIOCIDIN
CODEX LABS
DERMELEVE
DIAGNOSTIC SOLUSTIONS LAB
DUTCH TEST BY PRECISION ANALYTICAL
LILLY
REGENERON AND SANOFI
RESULTS RNA
Copyright 2023 © LearnHealth Inc. All rights reserved.